Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin 12 pseudogene 1 (CDH12P1) is classified as a pseudogene in the human genome. It is related to the protein-coding gene cadherin 12 (CDH12 or N-cadherin 2), a type II classical cadherin involved in calcium-dependent cell-cell adhesion, neuronal development, and has implications in cancer biology and neurological disorders[1][3][5]. However, CDH12P1 itself is a non-coding genomic locus and does not encode a functional protein[4][2]. While some pseudogenes are transcribed and can play regulatory roles—for example, acting in ceRNA networks to regulate oncogenes or tumor suppressors—CDH12P1 currently lacks specific published data supporting such a regulatory or functional role. It is not considered a therapeutic target, receptor, or enzyme, and has no known direct links to drugs or disease; its importance, if any, would derive from non-coding RNA activity, which has not yet been described for this locus[10][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin 12 pseudogene 1 (CDH12P1).